Referring Providers
BIDMC welcomes physician referrals and the opportunity to provide excellent care for your patients.
Cancer Center
About the Cancer Center at BIDMC
The Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) is renowned for exceptional cancer care and for pioneering discoveries that have led to powerful cancer treatment strategies.
We assemble leading experts to identify and deliver the best possible treatment plan for our patients. In our multidisciplinary clinics, our patients see all key specialists in one visit for easy access and coordinated planning. We offer a wide range of support services to help sustain patients and their families during and after treatment.
We provide our patients with the most advanced, personalized cancer therapies. This care is informed by our breakthrough research platforms incorporating RNA medicine, immunotherapies, organoids and co-clinical trials. As a leading academic medical center, BIDMC also offers a wide range of cancer-focused educational and training programs.
Awards & Collaborations
BIDMC was ranked #22 in the nation for cancer care by U.S. News & World Report in 2025.
BIDMC's Cancer Center is the only cancer center in Massachusetts, and one of only 34 in the country, to receive the Outstanding Achievement Award from the Commission on Cancer of the American College of Surgeons.
BIDMC is a member of the Harvard Cancer Collaborative. It continues to earn high marks in patient satisfaction surveys for our clinical excellence in cancer care and related services.
In 2012, the Cancer Center became one the first academic medical centers nationwide—and the first in Boston—to attain QOPI (Quality Oncology Practice Initiative) Certification by the American Society of Clinical Oncology (ASCO) and has maintained certification with ongoing quality improvement evaluations and initiatives.
BIDMC participates in the Eastern Cooperative Oncology Group, the Radiation Therapy Oncology Group, and the American College of Surgeons Oncology Group, and is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC) — Harvard's National Cancer Institute — designated comprehensive cancer center. We collaborate extensively on clinical trials with the NCI and DF/HCC.
Innovation in Cancer (ICan) Program
Next Generation Cancer Therapeutics
The Innovation in Cancer (ICan) program is part of the BIDMC Cancer Center Clinical Trials office. The goal of the program is to pioneer the development of the next generation of cancer therapeutics to improve the lives and outcomes of patients with all forms of cancers. Patients with advanced cancer that has not responded to standard therapy may benefit from this program. For those who qualify, this program offers the option to participate in early-stage research studies investigating new anti-cancer agents.
Innovation in Cancer (ICan) Program
330 Brookline Avenue Boston, MA 02215
Phone: 617-632-9272
Clinical Trials
The Innovation in Cancer (ICan) Program at BIDMC offers early-stage clinical trials, including Phase I studies, for patients with advanced cancers that have not responded to standard treatments. These trials focus on evaluating the safety and optimal dosing of new anti-cancer agents, such as novel chemotherapeutic drugs, targeted therapies and immunotherapies.
Investigating & Innovating New Cancer Therapies
The cancer research and clinical trials conducted under the Innovation in Cancer (ICan) program at BIDMC encompass a variety of novel therapies and techniques based on robust experimental and pre-clinical data, including:
- Unique agents designed to improve the effects of standard chemotherapy
- Targeted agents to disable a specific cellular pathway
- Innovative approaches to interfere with blood flow to tumors
- New chemotherapeutic agents
- State-of-the-art imaging techniques
Meet Our Innovation in Cancer Team
The specialists at the Innovation in Cancer program bring an advanced level of expertise and an ethical and compassionate approach to care.
Services
At the Cancer Center, our patients benefit from the level of cancer care provided by an academic medical center where expert clinicians and researchers collaborate closely to offer the latest innovative advancements.
Education & Training
As a leading academic medical center, BIDMC offers a wide range of cancer-focused opportunities, including surgical training and oncology educational and training programs.
Research & Clinical Trials
Programs
- Bladder Cancer Program
- Blood & Bone Marrow Cancer Program
- Bone & Soft Tissue Sarcoma Program
- Brain Tumor Center
- BreastCare Center
- Colon & Rectal Cancer Program
- Gastrointestinal Cancer Program
- Genitourinary Cancer Program
- Gynecological Oncology Program
- Head & Neck Cancer Program
- Kidney Tumor Program
- Liver Tumor Program
- Lung & Thoracic Cancer Program
- Melanoma & Skin Cancer Program
- Pancreatic Cancer Program
- Prostate Cancer Program
- Testicular Cancer Program
Learn more about these and other specialized programs by visiting our Programs page.
Related Departments & Divisions
Recognition for Cancer Care
BIDMC cancer care was ranked #22 in the nation by U.S. News & World Report in 2025.
